Journal of Applied Physiology Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 82: 531-537, 1997;
8750-7587/97 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karjalainen, J.
Right arrow Articles by Kujala, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karjalainen, J.
Right arrow Articles by Kujala, U.

Journal of Applied Physiology
Vol. 82, No. 2, pp. 531-537, February 1997
EXERCISE AND MUSCLE

Left ventricular mass, geometry, and filling in endurance athletes: association with exercise blood pressure

Jouko Karjalainen1, Matti Mäntysaari1, Matti Viitasalo2, and Urho Kujala3

1 Central Military Hospital and Research Institute of Military Medicine, 00301 Helsinki; 2 First Department of Medicine, Helsinki University Hospital, 00290 Helsinki; and 3 Research Institute for Sports and Exercise Medicine, 00250 Helsinki, Finland

ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
ACKNOWLEDGEMENTS
FOOTNOTES
REFERENCES


ABSTRACT

Karjalainen, Jouko, Matti Mäntysaari, Matti Viitasalo, and Urho Kujala. Left ventricular mass, geometry, and filling in endurance athletes: association with exercise blood pressure. J. Appl. Physiol. 82(2): 531-537, 1997.---We studied whether left ventricular (LV) mass and concentricity [relative myocardial volume (RMV)] are associated with exercise blood pressure (BP) in athletes. LV structure and filling were evaluated by Doppler echocardiography and BP in maximal bicycle ergometry and isometric handgrip tests on 32 male endurance athletes and 15 age-matched controls. Indexed LV mass was 145 ± 14 (SD) g/m in athletes and 93 ± 20 g/m in controls. Mass was not associated with BP at rest or in low-grade exercise, but with heavier exercise loads this association strengthened in athletes, being maximal at peak exercise (r = 0.65 for mass and 0.58 for indexed mass; P < 0.001). Multivariate analysis indicated that BP at peak exercise accounted for 34% and the amount of training for an additional 11% of the variance in indexed LV mass. RMV was 21% larger in athletes. Only the increase in systolic BP during handgrip explained significantly (19%) the variance in RMV. LV filling velocities were not associated with mass, RMV, or BP. We conclude that in endurance athletes LV mass is associated with BP in heavy dynamic exercise and LV concentricity with BP response in static exercise.

left ventricular hypertrophy; athletes' heart; endurance training


INTRODUCTION

LEFT VENTRICULAR (LV) mass is greater in competitive athletes by 45% on average compared with matched control subjects (20). The expansion in mass is due to growth in end-diastolic dimensions of the LV, LV wall thickness, or both. Diastolic function is preserved or even "supernormal" in athletes' heart (10, 17) in contrast to pathological LV hypertrophy, e.g., in hypertension, in which altered LV filling is detected early (26).

There is considerable variation among endurance athletes in the development of changes typical to athletes' heart, but it is not clear why the same type of training produces more hypertrophy in some athletes than in others and why the induced hypertrophy is more concentric in some than in others. Earlier studies (18, 20) have suggested that alterations in cardiac structure are mainly dependent on the type of training and/or athletic activity. Thus athletes participating in dynamic-type endurance sports tend to develop larger LV cavity dimensions without significant increase in wall thickness, whereas athletes involved in static exertion and exposed to a pressure load are more likely to develop greater LV wall thickness without significant increase in cavity dimensions. In contrast, echocardiographic studies have shown greater LV wall thickness to be common in endurance athletes (20), whereas this is often undetectable in athletes engaged in intense power training (25).

Exercise blood pressure (BP) is a more powerful determinant of LV hypertrophy in hypertensive patients than is BP at rest (28), and an exaggerated BP response to exercise is associated with LV hypertrophy in normotensive men, too (12). In this study we set out to explore the relationship between BP during dynamic and static exercise and LV hypertrophy, geometry, and filling in endurance athletes.


METHODS

Subjects. All male orienteering runners of the national training group of the Finnish Orienteering Association as well as male high-ranking long-distance runners (main events from 3,000 m to marathon) from Southern Finland were invited to take part in the study. Seventeen orienteering runners and 15 long-distance runners (participation rate 84%) gave their informed consent and joined the study, forming a combined group of 32 athletes aged from 22 to 31 yr with running as their main training modality. The maximal oxygen uptake in the athletes was 76 ± 5 (SD) ml · kg-1 · min-1 (range 69-89 ml · kg-1 · min-1) and did not differ significantly between orienteering and long-distance runners. The control group consisted of 15 age-matched sedentary men, Finnish army conscripts and physicians, none of whom exercised over 2 h/wk. Their mean result in the Cooper test (distance run in 12 min) was 2,730 m, an average Cooper test result in Finnish Army conscripts, and none of them ran over 3,000 m. All athletes and control subjects were free of known cardiac disease. Because anabolic steroid abuse and some other medications may cause cardiac muscle hypertrophy (21) and our aim was to study physiological responses, we selected subjects who used no medications.

Study protocol. All subjects participated in echocardiography and Doppler echocardiography, an isometric handgrip test, and a bicycle exercise test, in that order. All tests were done between 8 and 12 A.M. on the same day for each individual. The echocardiographic examinations and other tests were carried out independently, and investigators were blinded to results obtained by the other methods.

Echocardiography. Echocardiographic and Doppler studies were performed with an Acuson 128 instrument and V319 2.5-3.5-MHz transducer. Subjects were positioned at 45° left lateral position. To avoid including trabeculations in the wall thickness mesurements, an integrated M-mode and two-dimensional study was done to determine interventricular septal and LV posterior wall thickness and LV end-diastolic cavity dimension. First, two-dimensionally targeted M-mode recordings were obtained in parasternal long-axis view (30). Second, septal and posterior wall thicknesses were measured in parasternal long-axis view between mitral valve tips and papillary muscle from expanded two-dimensional images. Smaller numbers from either M-mode or two-dimensional measurements were accepted to represent the actual thicknesses of septum and posterior wall. The LV mass was calculated by using the formula by Devereux (5): mass = 0.8 · [1.04(septal thickness + end-diastolic diameter + posterior wall thickness)3 - end-diastolic diameter3] + 0.6 g.

LV length was measured at end diastole from the apical window at a view maximizing the ventricular length. Measurements were made from the mitral valve plane to the apical epicardium (L1) and to the apical endocardium (L2). The myocardial cross-sectional area of the LV was the difference between total LV area subtended by the epicardium (A1) and LV cavity area (A2) traced by using a midventricular short-axis view at the level of papillary muscle tips. The concentricity or eccentricity of the LV myocardium was evaluated by calculating the relative myocardial volume (RMV) by the following formula: RMV = (A1 · L1 - A2 · L2)/A2 · L2. This describes the relationship of the end-diastolic myocardial volume to end-diastolic chamber volume and is derived from the area-length model (31). Thus the measurements obtained for the calculation of RMV were independent of the measurements obtained for the calculation of LV mass. The sphericity of the LV chamber was evaluated by calculating the ratio of LV end diastolic diameter to ventricular length. In all two-dimensional measurements, the endocardial-LV cavity (white-black) interface was used for endocardial border definition (31).

Measurements of LV diastolic filling velocities were obtained in an apical four-chamber view by positioning the pulsed Doppler volume sample ~1 cm below the mitral annulus. Early peak flow velocity (VE) and peak atrial flow velocity (VA) were measured and the ratio VE/VA calculated.

All echocardiographic measurements were made by the same observer and obtained directly from the screen monitor with the aid of calipers and the instrument's trackball.

Handgrip test. In the isometric handgrip test the subjects squeezed a rubber ball in their dominant hand at 30% of the maximal squeezing force for 3 min. The test was done in the supine position. Heart rate and systolic and diastolic BPs were measured before and after 3 min of squeezing just before the release of handgrip.

Exercise test. A maximal exercise test was performed by the subjects on an electrically braked bicycle ergometer until exhaustion. The initial load was 50 W with subsequent increments of 50 W every 3 min. During the exercise test, a 12-lead electrocardiogram, heart rate, BP, and perceived exertion were recorded. BP was monitored in the subjects at rest after 5 min in the supine position, during exercise at 3-min intervals, and at peak exercise immediately before the subject was allowed to stop cycling. BP was measured sphygmomanometrically by the same observer in all tests.

Statistical methods. Results were expressed as means ± SD when appropriate. The strength of the associations between BPs and LV measurements was assessed by least- squares linear correlation. Comparison between athletes and control subjects, and between subgroups of athletes with differing LV mass index and RMV, was made by using the unpaired two-tailed t-test and by calculating the 95% confidence intervals. We also studied the predictors of indexed LV mass and RMV by using stepwise regression models (2R, BMDP Statistical Software, Berkeley, CA).


RESULTS

Comparison of athletes and control subjects. Characteristics of the athletes and control subjects are given in Table 1. The controls were significantly heavier, which was also reflected as higher body mass index and body surface area. The athletes had much lower heart rates, but resting BPs were similar between the groups.

Table 1. Characteristics of control subjects and endurance athletes


Control Subjects Athletes P Value

Age, yr 26 ± 3  (22-32) 26 ± 3  (22-34) 0.91
Height, cm 180 ± 6  (169-192) 181 ± 6  (168-191) 0.40
Weight, kg 78 ± 10  (63-96) 68 ± 5  (58-78) 0.003
Body surface area, m2  1.97 ± 0.15  (1.72-2.21) 1.87 ± 0.10  (1.66-2.05) 0.02
Body mass index, kg/m2 24.1 ± 2.7  (19.1-27.8) 20.6 ± 1.0  (18.1-22.7) <0.001
Heart rate, beats/min 66 ± 7  (56-79) 47 ± 6  (37-65) <0.001
Systolic blood pressure, mmHg 130 ± 13  (118-150) 131 ± 12  (110-155) 0.91
Diastolic blood pressure, mmHg 76 ± 9  (62-94) 78 ± 9  (62-98) 0.44
Training, h/wk <2 11 ± 2  (6-14)
Length of training, yr 12 ± 4  (4-22)

Values are means ± SD with range in parentheses for 15 control subjects and 32 athletes.

LV measurements in control subjects and athletes are shown in Table 2. The LV wall thicknesses and cavity dimensions were significantly larger in athletes, but the shape of the LV chamber was similar, as revealed by the equal ratio of ventricular diameter to length. The LV mass was 57% larger on average in the athletes, and the RMV was 21% greater.

Table 2. Echocardiographic left ventricular measurements in control subjects and athletes


Control Subjects
Athletes
P Value
Mean ± SD 95% CI Mean ± SD 95% CI

Septum, mm 8.8 ± 1.1  8.3-9.4 12.1 ± 1.1  11.6-12.7 <0.001
Posterior wall, mm 9.1 ± 1.0  8.6-9.5 11.2 ± 1.1  10.7-11.9 <0.001
End-diastolic diameter, mm 51.3 ± 2.9  49.8-52.7 54.8 ± 2.7  53.6-56.2 <0.001
Left ventricular length, mm 95.8 ± 5.3  93.3-98.4 103.3 ± 6.0  100.4-106.2 <0.001
LVEDD-to-length ratio 0.53 ± 0.04  0.52-0.56 0.53 ± 0.04  0.51-0.55 0.90
Mass, g 167 ± 37  149-185 263 ± 28  249-277 <0.001
Mass/body surface area, g/m2 84 ± 15  77-91 141 ± 13  134-147 <0.001
Mass/height, g/m 93 ± 20  83-102 145 ± 14  138-151 <0.001
Relative myocardial volume 1.06 ± 0.11  1.00-1.11 1.28 ± 0.2  1.18-1.37 <0.001
Transmitral VE, cm/s 65 ± 8  61-69 72 ± 9  68-77 0.009
Transmitral VA, cm/s 40 ± 11  37-43 31 ± 6  28-34 <0.001
VE/VA 1.66 ± 0.32  1.50-1.82 2.42 ± 0.61  2.12-2.72 <0.001

Values are for 15 control subjects and 32 athletes. CI, confidence interval; LVEDD, left ventricular end diastolic diameter; VE, early peak flow velocity; VA, peak atrial flow velocity.

During graded dynamic exercise testing, the systolic BPs were similar in controls and athletes at corresponding loads, but because heart rates were much lower in athletes (Table 3) the rate-pressure product was higher in controls (e.g., 37% higher at 150-W load). At peak exercise the rate-pressure products were similar between the groups because the heart rate remained lower in athletes despite a significantly higher systolic BP and a 100-W higher exercise load.

Table 3. Response in heart rate and systolic blood pressure during dynamic exercise


Exercise Load Control Subjects
Athletes
HR, beats/min SBP, mmHg HR · SBP, beats · min-1 · mmHg HR, beats/min SBP, mmHg HR · SBP, beats · min-1 · mmHg

 50 W 103 ± 11  150 ± 14  15,450 79 ± 9dagger 150 ± 12  11,850dagger
100 W 133 ± 19  175 ± 10  23,275 99 ± 9dagger 168 ± 12  16,632dagger
150 W 163 ± 18  191 ± 15  31,133 121 ± 10dagger 188 ± 15  22,780dagger
200 W 182 ± 12  199 ± 15  36,218 141 ± 10dagger 204 ± 14  28,764dagger
250 W 158 ± 10  219 ± 15  34,602
300 W 172 ± 8  225 ± 14  38,700
Peak exercise* 194 ± 10  204 ± 16  39,576 177 ± 8dagger 228 ± 16dagger 40,356

Values are means ± SD for 15 control subjects and 32 athletes. HR, heart rate; SBP, systolic blood pressure; HR · SBP, rate-pressure product. * Peak exercise load was 243 ± 32 W in control subjects and 333 ± 27 W in athletes, and exercise time was 13.4 ± 2.1 and 19.0 ± 1.6 min, respectively. dagger P < 0.001.

In the handgrip test, diastolic BP rose significantly more in athletes, whereas the differences in heart rate or systolic BP pressure responses were insignificant (Table 4). The maximal force of the handgrip was comparable (P > 0.05) in the athletic group [100 ± 16 (SD) kPa] and controls (109 ± 20 kPa).

Table 4. Heart rate and blood pressure increases in handgrip test


Control Subjects Athletes P Value

Rise in HR, beats/min 17 ± 12  15 ± 12  0.40
Rise in SBP, mmHg 29 ± 11  35 ± 13  0.10
Rise in DBP, mmHg 25 ± 13  32 ± 11  0.04

Values are means ± SD for 15 control subjects and 32 athletes. DBP, diastolic blood pressure.

Correlations of LV mass and geometry. Table 5 shows the correlation coefficients of LV mass and mass indexed to height. In the controls, LV mass had the strongest correlation with body weight and consequently high correlations with body surface area and body mass index, but there were no significant correlations to BP measurements. In athletes, the strongest correlate of LV mass was found to be peak exercise systolic BP, whereas of the body characteristics, height associated the strongest. After adjustment of LV mass to height, it still associated very significantly with peak exercise BP in athletes, although significant correlations with body characteristics were abolished. Figure 1 shows that the association of LV mass and systolic BP strengthened with increasing exercise load.

Table 5. Correlation of left ventricular mass and mass indexed to height with blood pressures and body characteristics


Control Subjects
Athletes
LVM, g Indexed LVM, g/m LVM, g Indexed LVM, g/m

Weight 0.72dagger 0.68* 0.42* 0.18
Height 0.40 0.26 0.48* 0.19
Body mass index 0.64* 0.67*  -0.03 0.02
Body surface area 0.70* 0.62* 0.46* 0.19
Rest SBP  -0.09  -0.07 0.23 0.25
Rest DBP  -0.19  -0.20  -0.11  -0.10
Peak exercise SBP 0.31 0.31 0.65dagger 0.58dagger
Increase in SBP in handgrip 0.10 0.17 0.12 0.30
Increase in DBP in handgrip  -0.09 0.10 0.09 0.26

Values are for 15 control subjects and 32 athletes. LVM, left ventricular mass. * P < 0.05.  dagger P < 0.01.


Fig. 1. Association of left ventricular mass (LVM) with systolic blood pressure (SBP) strengthens with increasing exercise load in bicycle ergometry in endurance athletes.
[View Larger Version of this Image (11K GIF file)]

To investigate the simultaneous effects of background factors on indexed LV mass in athletes, we included physical characteristics, amount of training, rest BP, rise in handgrip BP, and systolic BP at peak exercise as independent variables into a stepwise regression analysis. The two factors entering the model were systolic BP during peak exercise, accounting for 34%, and amount of training (hours/week), accounting for an additional 11% of the variance in indexed LV mass.

When RMV was correlated with BP measurements, significant correlations were found in athletes with systolic (r = 0.43, P < 0.05) and diastolic (r = 0.40, P < 0.05) BP increases in the handgrip test, and with peak exercise systolic BP (r = 0.42, P < 0.05). RMV in athletes was associated with myocardial mass (r = 0.55, P < 0.001), as shown in Fig. 2, but not with the shape (sphericity) of the LV chamber. The sphericity of the LV was associated with the LV end-diastolic diameter (r = 0.64, P < 0.001). In athletes, myocardial mass, RMV, and exercise BP responses were not associated with diastolic Doppler velocities of LV filling. In stepwise regression analysis, only the rise in systolic BP during handgrip entered the model, accounting for 19% of the variance in RMV.
Fig. 2. Relative myocardial volume describing concentricity of left ventricle in relation to LVM index. square , Control subjects; black-square, endurance athletes.
[View Larger Version of this Image (10K GIF file)]

Comparison of athletes with LV mass index below or above the group median of 143 g/m. When athletes were divided into two groups on the basis of a median LV mass index of 143 g/m, the groups differed significantly only in exercise systolic BP (Table 6). Figure 3 shows that the difference in exercise BPs increased with the rise in exercise load. Heart rate during exercise and exercise duration were similar. Athletes with a larger myocardial mass index tended to have larger RMV. BP responses to the handgrip test, as well as LV diastolic filling velocities, were similar between the groups.

Table 6. Blood pressures and echocardiographic measurements in athletes with left ventricular mass below or above group median of 143 g/m


LVM < 143 g/m
LVM > 143 g/m
P Value
Mean ± SD 95% CI Mean ± SD 95% CI

Age, yr 26.6 ± 3.7  24.8-28.6 26.1 ± 2.6  24.8-27.3 0.18
Height, cm 180 ± 6  177-183 183 ± 6  179-185 0.22
Weight, kg 67 ± 4  65-69 69 ± 6  66-72 0.33
Training, h/wk 10.1 ± 2.1  9-11.1 11.3 ± 2.0  10.4-12.3 0.10
Length of training, yr 11.5 ± 3.2  9.9-13.1 12.1 ± 5.1  10.6-13.7 0.70
LVEDD, mm 54.3 ± 2.5  53.2-55.6 55.5 ± 2.8  54.1-56.9 0.21
RMV 1.21 ± 0.15  1.13-1.28 1.35 ± 0.22  1.24-1.45 0.05
Rest SBP, mmHg 129 ± 10  124-134 132 ± 13  126-139 0.45
Rest DBP, mmHg 79 ± 7  75-83 78 ± 10  72.5-82.5 0.64
Peak exercise SBP, mmHg 221 ± 14  214-228 236 ± 14  229-242 <0.005
Peak heart rate, beats/min 177 ± 10  173-182 177 ± 7  173-180 0.80
Exercise duration, min 19.0 ± 1.5  18-20 19.1 ± 1.7  18-20 0.85
SBP increase in handgrip, mmHg 35 ± 11  29-41 34 ± 14  27-41 0.85
DBP increase in handgrip, mmHg 33 ± 9  28-37 32 ± 13  25.5-38 0.84
Peak VE, cm/s 73 ± 10  68-77 72 ± 9  68-76.5 0.88
Peak VA, cm/s 30 ± 7  27-34 32 ± 6  29-35 0.48
VE/VA 2.5 ± 0.7  2.2-2.8 2.3 ± 0.6  2.1-2.6 0.44

Values are for 16 athletes in each group. RMV, relative myocardial volume.


Fig. 3. Systolic blood pressure response in exercise is higher in endurance athletes with larger LVM index, and difference grows at increasing exercise loads. Max, maximum.
[View Larger Version of this Image (15K GIF file)]

Comparison of athletes with RMV below or above the group median of 1.26. Although athletes with larger RMV tended to have smaller LV end-diastolic diameter and bigger myocardial mass index, these differences were insignificant (Table 7). Athletes with more concentric LV hypertrophy had larger increases in both systolic and diastolic BPs during the handgrip test, whereas there were no significant differences in BPs during dynamic exercise or resting systolic BP. Resting diastolic BP was lower in the group with larger RMV. Diastolic LV filling velocities were not affected by the concentricity of the LV hypertrophy.

Table 7. Blood pressures and echocardiographic measurements in athletes with relative myocardial volume below or above group median of 1.26 


RMV < 1.26
RMV > 1.26
P Value
Mean ± SD 95% CI Mean ± SD 95% CI

Age, yr 26.6 ± 3.7  24.8-28.6 26.1 ± 2.6  24.8-27.3 0.66
Height, cm 181 ± 7  178-184 182 ± 6  179-185 0.82
Weight, kg 67 ± 7  64-70 68 ± 4  66-70 0.67
Training, h/wk 10.4 ± 2.2  9.3-11.5 11 ± 2  10-12 0.38
Length of training, yr 12.1 ± 4.7  9.9-14.2 11.6 ± 4.2  9.6-13.6 0.76
LVEDD, mm 55.7 ± 2.8  54.4-57.0 54.1 ± 2.6  52.8-55.3 0.09
LVM, g/m 139 ± 11  134-145 150 ± 15  143-157 0.02
Rest SBP, mmHg 131 ± 12  125-137 131 ± 11  125-136 0.89
Rest DBP, mmHg 82 ± 8  78-86 75 ± 9  70-79 0.01
Peak exercise SBP, mmHg 224 ± 16  216-232 232 ± 15  224-239 0.20
Peak heart rate, beats/min 177 ± 9  172-181 178 ± 7  174-181 0.71
Exercise duration, min 19.2 ± 1.5  18.4-19.9 18.9 ± 1.7  18.1-19.7 0.65
SBP increase in handgrip, mmHg 30 ± 10  24-36 40 ± 11  34-45 0.03
DBP increase in handgrip, mmHg 28 ± 12  22-34 37 ± 8  33-41 0.02
Peak VE, cm/s 70 ± 10  65-75 75 ± 7  71-79 0.11
Peak VA, cm/s 31 ± 6  28-34 32 ± 7  28-35 0.67
VE/VA 2.4 ± 0.6  2.1-2.7 2.5 ± 0.6  2.2-2.8 0.59

Values are for 16 athletes in each group.


DISCUSSION

Our study shows that, despite similar training and exercise capacity, there are considerable differences in the LV mass and geometry among top-level endurance athletes. Greater LV mass was associated with higher systolic BP in exercise, and the more strenuous the dynamic exercise, the stronger the association. Moreover, the concentricity of the LV hypertrophy was associated with the BP response in static exercise. Whereas athletes had higher peak exercise BPs than sedentary control subjects, exercise BPs were similar at similar exercise loads. In athletes, greater LV mass or concentricity did not impair LV velocities.

Earlier studies. Our results in endurance athletes resemble findings by Gottdiener et al. (12) in normotensive sedentary men with exaggerated BP responses to exercise. They found a corresponding association (r = 0.65) between LV mass and peak exercise systolic BP but no significant association with BP at rest or in low-grade exercise. However, they did not study the LV diastolic function in these normotensive men with LV hypertrophy, leaving unresolved whether the hypertrophy mimicked that found in athletes or resembled the pathological hypertrophy seen in hypertension. Similarly, Cigarroa et al. (3), in a study of cocaine abusers, found that subjects with LV hypertrophy had an exaggerated pressor response in exercise, in contrast to those without LV hypertrophy. However, this study did not measure the diastolic filling of the LV. Douglas et al. (7) measured mean exercise BP during an 8-h exercise test in 14 triathletes and found a strong correlation (r = 0.88) with LV mass, whereas diastolic function remained normal. They did not study control subjects, however. In contrast, Fagard and co-workers (8) did not find that exercise BP explained the variance in LV mass better than did rest BP. However, their subjects had the exercise test only up to 160 W, and most of them did not have LV hypertrophy. Their subjects thus resembled our control subjects, in whom no significant association was found between LV mass and rest or exercise BPs. Thus earlier studies and our study suggest that exercise BP is more strongly associated with LV mass in subjects with LV hypertrophy than in subjects with normal-sized hearts. Further, the association is strong only during strenuous exercise.

Adaptive vs. pathological LV hypertrophy. There are differences between the pathological LV hypertrophy and the adaptive hypertrophy of athletes. Diastolic filling is impaired in pathological hypertrophic states, in which the heart is under a pressure load such as in aortic stenosis (9). In arterial hypertension, the degree of pathological LV hypertrophy is directly related to the impairment of diastolic filling (11). On the other hand, because LV hypertrophy may precede the appearance of arterial hypertension (27, 32), it has been suggested that factors other than increased systemic vascular resistance are underlying LV hypertophy in this disease. These hormonal factors would also affect nonmyocyte cell populations such as fibroblasts in the myocardium, leading to remodeling of the interstitium (34) and thereby to an altered compliance of the myocardium reflected in diastolic filling velocities. Concentric LV hypertrophy in hypertension is associated with increased cardiovascular morbid event rate in subsequent years (14). There is no evidence, however, that the geometric pattern of LV hypertrophy in athletes would affect later cardiovascular morbidity.

Although LV hypertrophy often precedes hypertension in sedentary subjects, and an exaggerated BP response in exercise is regarded as a precursor of established hypertension at rest (19), there is no evidence that athletes with adaptive LV hypertrophy risk developing hypertension later. When elite athletes stopped their training, LV wall thickness reduced by 15-33% in 6-34 wk (21). However, there is some evidence that in older subjects engaged in heavy training, LV hypertrophy may become irreversible (22). On the other hand, former elite athletes, whether or not still in training, do not have an abnormal prevalence of hypertension (15).

Is an exaggerated exercise BP response the cause or consequence of LV hypertrophy? Studies reporting an association between LV mass and exercise BP in hypertension (28), normotensive men (12), cocaine abusers (3), and triathletes (7) all assumed greater pressure loads to have induced the hypertrophy. It has been speculated that, although the exaggerated BP response to strenuous exercise is not in itself a sufficient stimulus to induce LV hypertrophy, it could be a marker of similar BP responses to daily emotional and other stimuli (6).

An alternative and more plausible explanation in athletes is that exaggerated BP responses are the consequence and not the cause of the LV hypertrophy. Alexander and co-workers (1) found that, in subjects with stable heart rates due to pacemakers, static exercise increased BP by increasing stroke volume, with no change in the systemic vascular resistance. Greater LV mass is associated with larger stroke volume (16), and during exercise competitive athletes increase stroke volume more than do noncompetitive athletes (4). We did not measure stroke volume changes during exercise, but if athletes with larger LV mass were to increase their stroke volume during exercise more than athletes with smaller myocardial mass despite similar heart rates, this might explain the differences in BP responses. Our finding of a gradually widening difference in BP response at comparable heart rates with increasing exercise loads between athletes with larger or smaller LV mass is evidence for this mechanism. Both larger end-diastolic and smaller end-systolic chamber volumes may play a role in stroke volume increases (4). Moreover, because a dynamic exercise, running, was the main training modality in the studied athletes, it is unlikely that the enhanced BP response in static exercise induced the greater concentricity of the ventricular hypertrophy. The normal diastolic filling of even the thickest LVs in athletes is further evidence against the suggestion that higher exercise BP causes the more prominent LV hypertrophy.

The reason why some athletes develop larger and more concentric myocardial mass than others, despite similar training, may lay in genetic disposition. Familial aggregation of LV dimensions has been reported and it has been concluded that >60% of the variability in LV mass can be explained by heritable factors (33). Recent evidence implicates genes coding for components of the renin-angiotensin system in the pathogenesis of cardiac hypertrophy (13). In fact, preliminary data suggest that D polymorphism of the angiotensin-converting enzyme gene is strongly associated with the LV growth in response to exercise (23). In rat heart, different patterns of gene expression regulate myocardial hypertrophy in hypertensive hypertrophy as opposed to adaptive hypertrophy in which myocardial catecholamine levels are increased (2). There is much evidence that catecholamines could induce cardiac hypertrophy via direct stimulation of myocardial adrenoceptors (24).

One limitation of our study is that we used bicycle ergometry instead of treadmill running to get more reliable BP measurements during exercise. The athletes had trained running and could not achieve their maximal heart rate on bicycle ergometry because of premature fatique of leg muscles. Thus we could not measure the BP in athletes during their true maximal heart rate. It is highly probable, however, that if the true maximal exercise heart rate and BP had been achieved, the association between peak exercise BP and LV mass would have been still stronger, as suggested by Fig. 1. Further, there is the possibility that the hemodynamic response during cycling differs from that during running.

Conclusions. The endurance training response of LV hypertrophy is heterogenous. Larger LV mass is associated with higher systolic BP in strenuous dynamic exercise. The concentricity of the LV hypertrophy is associated with BP response in static exercise.


ACKNOWLEDGEMENTS

This study was supported by grants from the Finnish Defence Forces and from the Aarne Koskelo Foundation.


FOOTNOTES

Address for reprint requests: J. Karjalainen, Central Military Hospital, PL 50, 00301 Helsinki, Finland.

Received 28 May 1996; accepted in final form 21 October 1996.


REFERENCES

1. Alexander, T., D. B. Friedman, B. D. Levine, J. A. Pawelczyk, and J. H. Mitchell. Cardiovascular responses during static exercise. Studies in patients with complete heart block and dual chamber pacemakers. Circulation 89: 1643-1647, 1994. [Abstract/Free Full Text]
2. Buttrick, P. M., M. Kaplan, L. A. Leinwand, and J. Scheuer. Alterations in gene expression in the rat heart after chronic pathological and physiological loads. J. Mol. Cell. Cardiol. 26: 61-67, 1994. [Medline]
3. Cigarroa, C. G., J. D. Boehrer, E. Brickner, E. J. Eichhorn, and P. A. Grayborn. Exaggerated pressor response to treadmill exercise in chronic cocaine abusers with left ventricular hypertrophy. Circulation 86: 226-231, 1992. [Abstract/Free Full Text]
4. Crawford, M. H., M. A. Petru, and C. Rabinowitz. Effect of isotonic exercise training on left ventricular volume during upright exercise. Circulation 72: 1237-1243, 1985. [Abstract/Free Full Text]
5. Devereux, R. B. Detection of left ventricular hypertrophy by M-mode echocardiography. Hypertension Dallas 9, Suppl. II: 19-26, 1987.
6. Devereux, R. B. Does increased blood pressure cause left ventricular hypertrophy or vice versa? Ann. Intern. Med. 112: 157-159, 1990.
7. Douglas, P. S., M. L. O'Toole, D. B. Hiller, and N. Reichek. Left ventricular structure and function by echocardiography in ultraendurance athletes. Am. J. Cardiol. 58: 805-809, 1986. [Medline]
8. Fagard, R., J. Staessen, L. Thijs, and A. Amery. Relation of left ventricular mass and filling to exercise blood pressure and rest blood pressure. Am. J. Cardiol. 75: 53-57, 1995. [Medline]
9. Fifer, M. A., K. M. Borow, S. D. Colan, and B. H. Lorell. Early diastolic left ventricular function in children and adults with aortic stenosis. J. Am. Coll. Cardiol. 4: 1147-1155, 1985.
10. Finkelhor, R., L. Hanak, and R. Bahler. Left ventricular filling in endurance-trained subjects. J. Am. Coll. Cardiol. 8: 289-293, 1986. [Abstract]
11. Fouad, F. M., J. M. Slominski, and R. C. Tarazi. Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function. J. Am. Coll. Cardiol. 3: 1500-1503, 1984. [Abstract]
12. Gottdiener, J. S., J. Brown, J. Zoltick, and R. D. Fletcher. Left ventricular hypertrophy in men with normal blood pressure: relation to exaggerated blood pressure response to exercise. Ann. Intern. Med. 112: 161-166, 1990.
13. Iwai, N., N. Ohmichi, Y. Nakamura, and M. Kinoshita. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 90: 2622-2628, 1994. [Abstract/Free Full Text]
14. Koren, M. J., R. B. Devereux, P. N. Casale, D. D. Savage, and J. H. Laragh. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann. Intern. Med. 114: 345-352, 1991.
15. Kujala, U., J. Kaprio, S. Taimela, and S. Sarna. Prevalence of diabetes, hypertension, and ischemic heart disease in former elite athletes. Metabolism 43: 1255-1260, 1994. [Medline]
16. Kupari, M., P. Koskinen, and J. Virolainen. Correlates of left ventricular mass in a population sample aged 36 to 37 years. Focus on lifestyle and salt intake. Circulation 89: 1041-1050, 1994. [Abstract/Free Full Text]
17. Lewis, J., P. Spirito, A. Pelliccia, and B. J. Maron. Usefulness of Doppler echocardiographic assessment of diastolic filling in distinguishing "athlete's heart" from hypertrophic cardiomyopathy. Br. Heart J. 68: 296-300, 1992. [Abstract/Free Full Text]
18. Longhurst, J. C., A. R. Kelly, W. J. Gonyes, and J. H. Mitchell. Chronic training with static and dynamic exercise: cardiovascular adaptation and response to exercise. Circ. Res. 48, Suppl. 1: 171-178, 1981.
19. Mahoney, L. T., R. M. Schieken, W. R. Clarke, and R. M. Lauer. Left ventricular mass and exercise responses predict future blood pressure. The Muscatine study. Hypertension Dallas 12: 206-212, 1988. [Abstract/Free Full Text]
20. Maron, B. J. Structural features of the athlete heart as defined by echocardiography. J. Am. Coll. Cardiol. 7: 190-203, 1986. [Abstract]
21. Maron, B. J., A. Pelliccia, A. Spataro, and M. Granata. Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. Br. Heart J. 69: 125-128, 1993. [Abstract/Free Full Text]
22. Miki, T., Y. Yokota, T. Seo, and M. Yokoyama. Echocardiographic findings in 104 professional cyclists with follow-up study. Am. Heart J. 127: 898-905, 1994. [Medline]
23. Montgomery, H., P. Clarkson, C. Dollery, K. Prasad, M.-A. Losi, D. Statters, M. Jubb, J. McEwan, S. Humphies, and W. McKenna. D polymorphism of the angiotensin converting enzyme gene is strongly associated with the development of physiological left ventricular hypertrophy (Abstract). J. Am. Coll. Cardiol. 27: 244A, 1996.
24. Morgan, H. E., and K. M. Baker. Cardiac hypertrophy. Mechanical, neural, and endocrine dependence. Circulation 83: 13-25, 1991. [Free Full Text]
25. Pelliccia, A., A. Spataro, G. Caselli, and B. J. Maron. Absence of left ventricular wall thickening in athletes engaged in intense power training. Am. J. Cardiol. 72: 1048-1054, 1993. [Medline]
26. Phillips, R. A., M. E. Goldman, M. Ardeljan, R. Arora, H. B. Eison, B. Y. Yu, and L. R. Krakof. Determinants of abnormal left ventricular filling in early hypertension. J. Am. Coll. Cardiol. 14: 979-985, 1989. [Abstract]
27. Post, W. S., M. G. Larson, and D. Levy. Impact of left ventricular structure on the incidence of hypertension. The Framingham heart study. Circulation 90: 179-185, 1994. [Abstract/Free Full Text]
28. Ren, J.-F., A.-H. Hakki, M. N. Kotler, and A. S. Iskandrian. Exercise systolic blood pressure: a powerful determinant of increased left ventricular mass in patients with hypertension. J. Am. Coll. Cardiol. 5: 1224-1231, 1985. [Abstract]
29. Sachtleben, T. R., K. E. Berg, B. A. Elias, J. P. Cheatham, G. L. Felix, and J. F. Hofschire. The effect of anabolic steroids on myocardial structure and cardiovascular fitness. Med. Sci. Sports Exercise 25: 1240-1245, 1993. [Medline]
30. Sahn, D. J., A. DeMaria, J. Kisslo, and A. Weyman. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978. [Abstract/Free Full Text]
31. Schiller, N. B., P. M. Shah, M. Crawford, A. DeMaria, R. Devereux, M. Feigenbaum, H. Gutgesell, N. Reichek, D. Sahn, I. Schnittger, N. H. Silverman, and A. J. Tajik. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J. Am. Soc. Echocard. 2: 358-367, 1989. [Medline]
32. Simone, G., de, R. B. Devereux, M. J. Roman, Y. Schlussel, L. H. Alderman, and J. H. Laragh. Echocardiographic left ventricular mass and electrolyte intake predict arterial hypertension. Ann. Intern. Med. 114: 202-209, 1991.
33. Verhaaren, H. A., R. M. Schieken, M. Mosteller, J. K. Hewitt, L. J. Eaves, and W. E. Nance. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Virginia twin study). Am. J. Cardiol. 68: 661-668, 1991. [Medline]
34. Weber, K. T. Cardiac interstitium: extracellular space of the myocardium. In: The Heart and Cardiovascular System, edited by H. A. Fozzard, E. Haber, D. B. Jennings, A. N. Katz, and H. E. Morgan. New York: Raven, 1992, p. 1456-1480.

0161-7567/97 $5.00 Copyright © 1997 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. L. Baggish, K. Yared, F. Wang, R. B. Weiner, A. M. Hutter Jr., M. H. Picard, and M. J. Wood
The impact of endurance exercise training on left ventricular systolic mechanics
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1109 - H1116.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. Brassard, A. Ferland, V. Gaudreault, N. Bonneville, J. Jobin, and P. Poirier
Elevated peak exercise systolic blood pressure is not associated with reduced exercise capacity in subjects with Type 2 diabetes
J Appl Physiol, September 1, 2006; 101(3): 893 - 897.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
T Venckunas, A Stasiulis, and R Raugaliene
Concentric myocardial hypertrophy after one year of increased training volume in experienced distance runners
Br. J. Sports Med., August 1, 2006; 40(8): 706 - 709.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Hernandez, A. de la Rosa, A. Barragan, Y. Barrios, E. Salido, A. Torres, B. Martin, I. Laynez, A. Duque, A. De Vera, et al.
The ACE/DD genotype is associated with the extent of exercise-induced left ventricular growth in endurance athletes
J. Am. Coll. Cardiol., August 6, 2003; 42(3): 527 - 532.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. M. Pluim, A. H. Zwinderman, A. van der Laarse, and E. E. van der Wall
The Athlete’s Heart : A Meta-Analysis of Cardiac Structure and Function
Circulation, January 25, 2000; 101(3): 336 - 344.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Karjalainen, U. M. Kujala, A. Stolt, M. Mantysaari, M. Viitasalo, K. Kainulainen, and K. Kontula
Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes
J. Am. Coll. Cardiol., August 1, 1999; 34(2): 494 - 499.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. L. Stepien, K. W. Hinchcliff, P. D. Constable, and J. Olson
Effect of endurance training on cardiac morphology in Alaskan sled dogs
J Appl Physiol, October 1, 1998; 85(4): 1368 - 1375.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karjalainen, J.
Right arrow Articles by Kujala, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karjalainen, J.
Right arrow Articles by Kujala, U.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online